Erratum: FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD (Scientific Reports (2013) 3 (2388) DOI: 10.1038/srep02388);FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Fujioka, Yusuke ^a   Ishigaki, Shinsuke ^a   Masuda, Akio ^a   Iguchi, Yohei ^a   Udagawa, Tsuyoshi ^a   Watanabe, Hirohisa ^a   Katsuno, Masahisa ^a   Ohno, Kinji ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN; RNA BINDING PROTEIN; TRANSCRIPTOME;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY; TISSUE DISTRIBUTION;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; FRONTOTEMPORAL LOBAR DEGENERATION; GENE EXPRESSION REGULATION; HUMANS; NERVE TISSUE PROTEINS; NEURONS; RNA-BINDING PROTEIN FUS; TISSUE DISTRIBUTION; TRANSCRIPTOME;

EID: 84882380821     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03300     Document Type: Erratum

References (41)

1. Rothstein, J. D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65 Suppl 1, S3-9 (2009).
2. Saxena, S. & Caroni, P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35-48 (2011).
3. Strong, M. J. & Volkening, K. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis? FEBS J 278, 3569-77 (2011).
4. Lagier-Tourenne, C. & Cleveland, D. W. Rethinking ALS: the FUS about TDP-43. Cell 136, 1001-4 (2009).
5. Munoz, D. G. et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118, 617-27 (2009).
6. Neumann,M. et al.Anew subtype of frontotemporal lobar degenerationwith FUS pathology. Brain 132, 2922-31 (2009).
7. Van Langenhove, T., van der Zee, J.&Van Broeckhoven,C. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. Ann Med 44, 817-28 (2012).
8. Kwiatkowski, T. J., Jr. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-8 (2009).
9. Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-11 (2009).
10. Deng, H. X. et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67, 739-48 (2010).
11. Bosco, D. A. et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19, 4160-75 (2010).
12. Dormann, D. et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841-57 (2010).
13. Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H. & Suzuki, N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 69, 152-62 (2011).
14. Kino, Y. et al. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res 39, 2781-98 (2011).
15. Wang, J. W., Brent, J. R., Tomlinson, A., Shneider, N. A. & McCabe, B. D. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Invest 121, 4118-26 (2011).
16. Kabashi, E. et al. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet 7, e1002214 (2011).
17. Boillee, S. et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-92 (2006).
18. Yamanaka, K. et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A 105, 7594-9 (2008).
19. Yamanaka, K. et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11, 251-3 (2008).
20. Ishigaki, S. et al. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep 2, 529 (2012).
21. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57 (2009).
22. Dennis, G., Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3 (2003).
23. Licatalosi, D. D. et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464-9 (2008).
24. Masuda, A. et al. CUGBP1 and MBNL1 preferentially bind to 39 UTRs and facilitate mRNA decay. Sci Rep 2, 209 (2012).
25. Xue, Y. et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell 36, 996-1006 (2009).
26. Keren, H., Lev-Maor, G. & Ast, G. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 11, 345-55 (2010).
27. Grabowski, P. Alternative splicing takes shape during neuronal development. Curr Opin Genet Dev 21, 388-94 (2011).
28. Yeo, G., Holste, D., Kreiman, G. & Burge, C. B. Variation in alternative splicing across human tissues. Genome Biol 5, R74 (2004).
29. Clark, T. A. et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 8, R64 (2007).
30. Geser, F. et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65, 636-41 (2008).
31. Ravits, J. M. & La Spada, A. R. ALS motor phenotype heterogeneity, focality, and spread: deconstructingmotor neuron degeneration. Neurology 73, 805-11 (2009).
32. Da Cruz, S. & Cleveland, D. W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21, 904-19 (2011).
33. Lagier-Tourenne, C. et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15, 1488-97 (2012).
34. Rogelj, B. et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2, 603 (2012).
35. Orozco, D. et al. Loss of fused in sarcoma (FUS) promotes pathological Tau splicing. EMBO Rep 13, 759-64 (2012).
36. Yoshida, M. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies. Neuropathology 26, 457-470 (2006).
37. Hong,M. et al.Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-7 (1998).
38. Saitsu, H. et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet 40, 782-8 (2008).
39. Tian, J. H., Das, S. & Sheng, Z. H. Ca21-dependent phosphorylation of syntaxin- 1A by the death-associated protein (DAP) kinase regulates its interaction with Munc18. J Biol Chem 278, 26265-74 (2003).
40. Verheij, C. et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363, 722-4 (1993).
41. Campeau, E. et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4, e6529 (2009).